meipharma.com - היקף יתרות המזומנים של החברה MEIP

סמלים רשמיים של חברת MEI Pharma (MEIP)

MEI Pharma, Inc. (MEIP) possesses immense expansion potential within the global oncology market, as evidenced by the time trajectory on the GURU.Markets chart, where the cash position reaches the 0.00 mark. The company generates revenue through the implementation of small molecules for lymphoma therapy. Operational resilience is based on delegating clinical trials to external CRO centers, which eliminates the risk of disruptions.

MEIP - היקף יתרות המזומנים של החברה MEI Pharma Corp בטווח 04.07.2022 - 11.09.2025

פילוחי מדדים ואנליטיקה של חברת MEI Pharma (MEIP)

- שווי מניות ותחזית קונצנזוס למחירים:
- נתוני יתרות מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:MEI Pharma, Inc. MEIP
מוצר ממותג של meipharma.com

This indicator reflects the volume of highly liquid assets available to promptly cover expenses without resorting to external borrowing. Analyzing changes in cash on hand allows for an assessment of the business's actual financial stability and margin of safety. The metric measures the net cash reserve, minimizing the impact of accounting assumptions on the solvency assessment. For MEI Pharma, Inc. (MEIP), such funds are critical for financing costly clinical trials of oncology drugs. Maintaining liquidity ensures the company's independence within strategic partnerships for the development of targeted therapy.